Chatelut E - Search Results

1

Phase I dose-escalation study of pazopanib combined with bevacizumab in patients with metastatic renal cell carcinoma or other advanced tumors.

Négrier S, Pérol D, Bahleda R, Hollebecque A, Chatelut E, Boyle H, Cassier P, Metzger S, Blanc E, Soria JC, Escudier B. Négrier S, et al. Among authors: chatelut e. BMC Cancer. 2017 Aug 15;17(1):547. doi: 10.1186/s12885-017-3527-7. BMC Cancer. 2017. PMID: 28810837 Free PMC article. Clinical Trial.

2

Pharmacokinetics and toxicity of two modalities of etoposide infusion in metastatic non-small-cell lung carcinoma.

Chatelut E, Chevreau C, Blancy E, Lequellec A, Canal P, Roche H, Houin G, Bugat R. Chatelut E, et al. Cancer Chemother Pharmacol. 1990;26(5):365-8. doi: 10.1007/BF02897295. Cancer Chemother Pharmacol. 1990. PMID: 2170043

3

[Phase I trial and pharmacokinetics of VM 26 combined with cisplatin administered by the intraperitoneal route without mixing time].

Chatelut E, Canal P, De Forni M, Chevreau C, Houin G, Bugat R. Chatelut E, et al. Bull Cancer. 1989;76(8):893-6. Bull Cancer. 1989. PMID: 2620120 French. No abstract available.

4

Phase I/pharmacokinetic study of intraperitoneal teniposide (VM 26).

Canal P, Bugat R, Chatelut E, Pinel MC, Houin G, Plusquellec Y, Carton M. Canal P, et al. Among authors: chatelut e. Eur J Cancer Clin Oncol. 1989 May;25(5):815-20. doi: 10.1016/0277-5379(89)90126-0. Eur J Cancer Clin Oncol. 1989. PMID: 2737218

5

A pharmacologically guided phase I study of carboplatin in combination with methotrexate and vinblastine in advanced urothelial cancer.

Chatelut E, Chevreau C, Brunner V, Martinez M, Houin G, Bugat R, Canal P. Chatelut E, et al. Cancer Chemother Pharmacol. 1995;35(5):391-6. doi: 10.1007/s002800050252. Cancer Chemother Pharmacol. 1995. PMID: 7850920 Clinical Trial.

6

[Concomitant association of radiotherapy and chemotherapy (CDDP 4-6 mg/m2/daily in continuous i.v. administration) in locally advanced ORL tumors].

Bachaud JM, Albin N, Gay C, Chatelut E, Benchalal M, David JM, Boneu A, Serrano E, Canal P, Daly-Schveitzer N. Bachaud JM, et al. Among authors: chatelut e. Bull Cancer. 1994 Mar;81(3):212-8. Bull Cancer. 1994. PMID: 7894129 French.

7

[Intraperitoneal high dose chemotherapy as consolidation treatment for advanced ovarian carcinoma: a pilot study].

Gladieff L, Chatelut E, Gaspard MH, Skaf R, de Forni M, Mihura J, Canal P, Bugat R. Gladieff L, et al. Among authors: chatelut e. Bull Cancer. 1999 Jul-Aug;86(7-8):673-7. Bull Cancer. 1999. PMID: 10477384 Free article. French.

8

[Pharmacokinetics and individual dose adjustment of carboplatin].

Chatelut E, Canal P, Bugat R. Chatelut E, et al. Bull Cancer. 2000 Aug;87 Spec No:17-23. Bull Cancer. 2000. PMID: 11082718 Free article. Review. French.

9

Population pharmacokinetics of oxaliplatin.

Delord JP, Umlil A, Guimbaud R, Grégoire N, Lafont T, Canal P, Bugat R, Chatelut E. Delord JP, et al. Among authors: chatelut e. Cancer Chemother Pharmacol. 2003 Feb;51(2):127-31. doi: 10.1007/s00280-002-0550-3. Epub 2002 Dec 4. Cancer Chemother Pharmacol. 2003. PMID: 12647013

10

Individual dosing of carboplatin based on drug monitoring in children receiving high-dose chemotherapy.

Rubie H, Doz F, Vassal G, Chastagner P, Gentet JC, Urien S, Bastian G, Drouard-Troalen L, Barberi-Heyob M, Catalin J, Chatelut E; Pharmacology Group of the Société Française de Pédiatrie Oncologique. Rubie H, et al. Among authors: chatelut e. Eur J Cancer. 2003 Jul;39(10):1433-8. doi: 10.1016/s0959-8049(03)00314-9. Eur J Cancer. 2003. PMID: 12826047 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

242 results

Search Page